3rd international symposium on genetic anticancer agents.
The 3rd International Symposium on Genetic Anticancer Agents was an initiative of NDDO Research Foundation, which is an internationally operating organisation exclusively devoted to the research and development of new strategies for the treatment of cancer. The meeting focused on the preclinical and clinical development of various genetic agents for cancer treatment. Leading world experts came to Amsterdam to present recent results of their highly advanced research and to discuss novel approaches to cancer treatment. In addition to the scientific sessions, the organisers prepared an educational session devoted to the development process of a gene therapy product and to the design of clinical trials. The educational session aroused a great interest from the participants. The meeting highlights from different scientific sessions are presented.
Wysocki
Piotr J
PJ
Department of Cancer Immunology, Chair of Oncology, USOMS, at GreatPoland Cancer Center, Garbary Street 15, 61-866 Poznan, Poland. pwysocki@plusnet.pl
Mackiewicz-Wysocka
Malgorzata
M
D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000628:therapy*; D014779:Virus Replication